
Global spending on the fight against malaria has stalled, falling $2 billion short of World Health Organization (WHO) targets, according …

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …
American sociologist Donald Light has made a provocative assessment of the pharma industry, saying the industry is able to exaggerate …

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …

